EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Sulfated Alginate for Biomedical Applications

Alexandra L Mutch iD, Jiankun Yang iD, Vito Ferro iD, Anitha A iD, Lisbeth Grøndahl iD

Macromolecular Bioscience · 2024-11 · 24 (11)

DOI: 10.1002/mabi.202400237 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Macromolecular Bioscience, online erschienen am 30.07.2024. Verfasst von Alexandra L Mutch und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemistry and Molecular Biosciences, The University of Queensland, Australia. Hauptthemen laut MEDLINE: Alginates, Biocompatible Materials. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 143 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Australian Government, University of Queensland, China Scholarship Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alginate (Alg) polymers have received much attention due to the mild conditions required for gel formation and their good bio‐acceptability. However, due to limited interactions with cells, many drugs, and biomolecules, chemically modified alginates are of great interest. Sulfated alginate (S–Alg) is a promising heparin‐mimetic that continues to be investigated both as a drug molecule and as a component of biomaterials. Herein, the S–Alg literature of the past five years (2017–2023) is reviewed. Several methods used to synthesize S–Alg are described, with a focus on new advances in characterization and stereoselectivity. Material fabrication is another focus and spans bulk materials, particles, scaffolds, coatings, and part of multicomponent biomaterials. The new application of S–Alg as an antitumor agent is highlighted together with studies evaluating safety and biodistribution. The high binding affinity of S–Alg for various drugs and heparin‐binding proteins is exploited extensively in biomaterial design to tune the encapsulation and release of these agents and this aspect is covered in detail. Recommondations include publishing key material properties to allow reproducibility, careful selection of appropriate sulfation strategies, the use of cross–linking strategies other than ionic cross–linking for material fabrication, and more detailed toxicity and biodistribution studies to inform future work.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AlginatesBiocompatible MaterialsHumansAnimalsHeparinSulfatesAntineoplastic Agents

Stichwörter der Autor:innen

alginate sulfatebiomaterialsheparin‐binding proteinspropylene glycol alginate sodium sulfate (PSS)therapeutic delivery

Substanzen

AlginatesBiocompatible MaterialsHeparinSulfatesAntineoplastic Agents

Autor:innen und Institutionen

  • School of Chemistry and Molecular Biosciences, The University of Queensland, Australia.

ORCID-Profile: Alexandra L Mutch, Jiankun Yang, Vito Ferro, Anitha A, Lisbeth Grøndahl

Förderung

  • Australian Government
  • University of Queensland
  • China Scholarship Council
  • National Foundation for Medical Research and Innovation

Zitieren

APA

Mutch, A. L., Yang, J., Ferro, V., A, A., & Grøndahl, L. (2024). Sulfated Alginate for Biomedical Applications. Macromolecular Bioscience, 24(11). https://doi.org/10.1002/mabi.202400237

Vancouver

Mutch AL, Yang J, Ferro V, A A, Grøndahl L. Sulfated Alginate for Biomedical Applications. Macromolecular Bioscience. 2024;24(11). doi:10.1002/mabi.202400237

BibTeX
@article{Mutch2024,
  author = {Mutch, Alexandra L and Yang, Jiankun and Ferro, Vito and A, Anitha and Grøndahl, Lisbeth},
  title = {Sulfated Alginate for Biomedical Applications},
  journal = {Macromolecular Bioscience},
  year = {2024},
  volume = {24},
  number = {11},
  doi = {10.1002/mabi.202400237}
}
Kostenlos starten →